oxotremorine has been researched along with Pancreatic Neoplasms in 1 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chien, JL | 1 |
| Warren, JR | 1 |
1 other study available for oxotremorine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Muscarinic receptor coupling to intracellular calcium release in rat pancreatic acinar carcinoma.
Topics: Animals; Binding, Competitive; Calcium; Carbachol; Carcinoma; N-Methylscopolamine; Oxotremorine; Pan | 1986 |